EUVIMEDEUVIMED entdecken
Crossref

Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis

Ziming Hou, Jie Hu, Xing Liu, Zeya Yan, Kenan Zhang, Shengyu Fang, Tao Jiang, Yinyan Wang

Journal of Neuro-Oncology · 2023

DOI: 10.1007/s11060-023-04420-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2023. Verfasst von Ziming Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Luhe Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Neurosurgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Beijing Medical Development Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Extensive surgical resection has been found to be associated with longer survival in patients with gliomas, but the interactive prognostic value of molecular pathology of the surgical resection is unclear. This study evaluated the impact of molecular pathology and clinical characteristics on the surgical benefit in WHO grade 3 IDH-mutant gliomas. METHODS: Clinical and pathological information of 246 patients with WHO grade 3 IDH-mutant gliomas were collected from the Chinese Glioma Genome Atlas database (2006-2020). The role of the extent of resection on overall survival, stratified by molecular pathology and clinical characteristics, was investigated. We then assessed prognostic factors using a univariate log-rank test and multivariate Cox proportional hazards model in the subgroups. RESULTS: The extent of resection was an independent prognostic factor in the entire cohort, even when adjusted for molecular pathology. Gross total resection was found to be associated with longer survival in all patients and in the astrocytoma group but not in the oligodendroglioma group. Compared with subtotal resections, gross total resections resulted in a longer survival time for astrocytoma patients aged ≤ 45 years. However, there was no survival benefit from total resection in patients with astrocytoma aged > 45 years. CONCLUSIONS: Extensive resection benefits only a proportion of patients with WHO grade 3 IDH-mutant gliomas. Younger patients with astrocytomas had survival benefits from extensive resection. In addition to clinical characteristics (especially age), molecular pathology impacted prognosis in patients with gliomas. Our findings provide guiding information to neurosurgeons while planning surgeries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsNeurosurgical ProceduresHumansFemaleMaleMiddle AgedAdultPrognosisMutationNeoplasm GradingYoung AdultAgedIsocitrate DehydrogenaseSurvival RateAdolescentDatabases, FactualChinaFollow-Up StudiesWorld Health OrganizationEast Asian People

Stichwörter der Autor:innen

Chinese Glioma Genome AtlasExtent of resectionMolecular pathologySurvivalWHO grade 3 gliomas

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Department of Neurosurgery, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, #119 Area A, Nansihuanxi Road, Fengtai District, Beijing, 100070, China.
  • Beijing Neurosurgical Institute, Capital Medical University, #119 Area B, Nansihuanxi Road, Fengtai District, Beijing, 100070, China.
  • Beijing Neurosurgical Institute, Capital Medical University, #119 Area B, Nansihuanxi Road, Fengtai District, Beijing, 100070, China. fangtuo1@aliyun.com.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, #119 Area A, Nansihuanxi Road, Fengtai District, Beijing, 100070, China. tiantanyinyan@126.com.
  • Beijing Neurosurgical Institute, Capital Medical University, #119 Area B, Nansihuanxi Road, Fengtai District, Beijing, 100070, China. tiantanyinyan@126.com.

Förderung

  • Beijing Medical Development Project
  • National Natural Science Foundation of China

Zitieren

APA

Hou, Z., Hu, J., Liu, X., Yan, Z., Zhang, K., Fang, S., Jiang, T., & Wang, Y. (2023). Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-023-04420-5

Vancouver

Hou Z, Hu J, Liu X, Yan Z, Zhang K, Fang S, et al. Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis. Journal of Neuro-Oncology. 2023. doi:10.1007/s11060-023-04420-5

BibTeX
@article{Hou2023,
  author = {Hou, Ziming and Hu, Jie and Liu, Xing and Yan, Zeya and Zhang, Kenan and Fang, Shengyu and Jiang, Tao and Wang, Yinyan},
  title = {Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis},
  journal = {Journal of Neuro-Oncology},
  year = {2023},
  doi = {10.1007/s11060-023-04420-5}
}
Kostenlos starten →